Infliximab or cyclosporine as rescue therapy in hospitalized patients with steroid-refractory ulcerative colitis: a retrospective observational study

Mats Sjöberg, Andrea Walch, Mina Meshkat, Anders Gustavsson, Gunnar Järnerot, Harald Vogelsang, Erik Hertervig, Gottfried Novacek, Ingalill Friis-Liby, Lars Blomquist, Sieglinde Angelberger, Per Karlen, Christer Grännö, Mogens Vilien, Magnus Ström, Hans Verbaan, Per M Hellström, Clemens Dejaco, Anders Magnuson, Jonas HalfvarsonWalter Reinisch, Curt Tysk

58 Citationer (Scopus)

Abstract

Cyclosporine (CsA) or infliximab (IFX) are used as rescue therapies in steroid-refractory, severe attacks of ulcerative colitis (UC). There are no data comparing the efficacy of these two alternatives.
OriginalsprogEngelsk
TidsskriftInflammatory Bowel Diseases
Vol/bind18
Udgave nummer2
Sider (fra-til)212-8
Antal sider7
ISSN1078-0998
DOI
StatusUdgivet - 2012

Fingeraftryk

Dyk ned i forskningsemnerne om 'Infliximab or cyclosporine as rescue therapy in hospitalized patients with steroid-refractory ulcerative colitis: a retrospective observational study'. Sammen danner de et unikt fingeraftryk.

Citationsformater